Hydroxyzine in Acute Hypertension: A Cohort Study.

Jakub Nozewski,Piotr Remiszewski,Kinga Filipek,Agata Pisklak,Aleksandra Abramczyk,Stanislaw Pyzel,Daniel Sliz

DOI: https://doi.org/10.1101/2024.09.30.24314673

2024-10-02

Abstract:Captopril, an ACE inhibitor, is widely used for acute hypertensive episodes, while hydroxyzine, an antihistamine with sedative and anxiolytic effects, is also employed in Poland despite limited research on its efficacy for this purpose. o our knowledge, no prior studies have specifically investigated the direct impact of hydroxyzine on hypertension, despite its common use in Polish medical practice. A retrospective cohort analysis of 2144 patients who required emergency intervention for hypertension or had high blood pressure during other interventions. Effectiveness was based on blood pressure improvement post-intervention. 84.28% of interventions were performed by basic emergency teams, and 15.72% by specialist teams. Captopril and hydroxyzine were the most commonly used medications. Blood pressure improved in 36.61% of patients, with no improvement in 41.47%. Hydroxyzine was more frequently administered by paramedic teams, while captopril was favored by specialist teams. There were no statistically significant differences in captopril use across age groups, with approximately 80% receiving it. Hydroxyzine use did not vary significantly by age, though its overall use was low. Hydroxyzine showed a non-significant trend towards greater blood pressure reduction compared to captopril. Captopril is the primary treatment for acute hypertension in emergency settings, but hydroxyzine may have potential benefits, especially in patients with anxiety-related hypertension. However, due to the lack of significant evidence and current guidelines advising against hydroxyzine in elderly patients, further research is needed to establish protocols and optimize hypertension treatment strategies. Additionally, incorporating anxiolytics into guidelines and an official statement on their use would aid clinical practice.

Cardiovascular Medicine

What problem does this paper attempt to address?

The main issue this paper attempts to address is the evaluation of the effectiveness of the antihistamine Hydroxyzine in the treatment of acute hypertension, and its comparison with the commonly used angiotensin-converting enzyme inhibitor Captopril. Specifically, the researchers aim to explore the efficacy and potential advantages of Hydroxyzine in the treatment of acute hypertension in Polish medical practice through a retrospective cohort analysis, particularly in patients with anxiety-related hypertension.

### Main Research Questions:
1. **Efficacy of Hydroxyzine in Acute Hypertension**: The researchers aim to understand the actual application effect of Hydroxyzine in acute hypertension, especially in the absence of sufficient research, and whether it can effectively lower blood pressure.
2. **Comparison with Captopril**: The researchers aim to compare the effects of Hydroxyzine and Captopril in the treatment of acute hypertension, particularly their performance across different age groups, genders, and types of emergency teams.
3. **Management of Anxiety-Related Hypertension**: The researchers aim to explore the potential advantages of Hydroxyzine in patients with anxiety-related hypertension and its prospects in clinical practice.

### Research Background:
- **Definition and Management of Acute Hypertension**: Acute hypertension refers to a significant increase in blood pressure, which may be accompanied by acute organ complications. Common symptoms include headache, visual disturbances, chest pain, shortness of breath, dizziness, and neurological deficits.
- **Common Medications**: Captopril is currently a commonly used medication in the treatment of acute hypertension, while Hydroxyzine, despite its sedative and anti-anxiety effects, lacks sufficient research in its application for acute hypertension.
- **Significance of the Study**: Although the European Society of Cardiology guidelines do not recommend the use of Hydroxyzine in hypertensive emergencies, the researchers believe it is necessary to further explore its potential value in specific situations, especially for the management of anxiety-related hypertension.

Through these research questions, the paper aims to provide more evidence to support clinical practice, optimize treatment strategies for acute hypertension, and provide references for future clinical guidelines.